Ann Donohue
Plus aucun poste en cours
Historique de carrière de Ann Donohue
Anciens postes connus de Ann Donohue
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| CARTESIAN THERAPEUTICS, INC. | Comptroller/Controller/Auditor | 21/05/2021 | 20/09/2021 |
| Directeur Financier/CFO | 21/05/2021 | 20/09/2021 | |
| Corporate Officer/Principal | 20/09/2021 | - |
Formation de Ann Donohue
| Wallace E Carroll School of Management | Graduate Degree |
Statistiques
Internationale
| Etats-Unis | 3 |
Opérationnelle
| Comptroller/Controller/Auditor | 1 |
| Director of Finance/CFO | 1 |
| Corporate Officer/Principal | 1 |
Sectorielle
| Health Technology | 2 |
| Consumer Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Selecta Biosciences, Inc.
 Selecta Biosciences, Inc. BiotechnologyHealth Technology Selecta Biosciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research and development of nanoparticle immunomodulatory drugs for the treatment and prevention of human diseases. Its portfolio includes pipeline, autoimmune, gene therapy, and biologic therapy. The company was founded by Omid C. Farokhzad, Robert S. Langer Jr., and Ulrich von Andrian on December 10, 2007 and is headquartered in Watertown, MA. | Health Technology |
- Bourse
- Insiders
- Ann Donohue
- Expérience
